Renalytix Plc (AIM:RENX)
5.87
-0.28 (-4.55%)
Sep 25, 2026, 4:27 PM GMT
Renalytix Earnings Call Transcripts
Fiscal Year 2025
-
Revenue is on track for $3.2M in FY2025 with 20% quarterly growth, driven by Medicare coverage and direct-to-doctor sales. Operational improvements have reduced costs and turnaround times, while strategic pharma collaborations and a strong US focus support future expansion.